|
|
 |
|
Viewing report
|
|
 |
 |
Achieving Market Dominance Through Reformulation: A Strategic Insight
Business Insights, Aug 2001
More than $165bn in ethical revenues may be cannibalised as a consequence of patent expiry from 31 leading drug patent expirations between 2000 and 2005. In view of this, pharmaceutical reformulation represents a viable option to maintain market leadership for key drugs. Achieving Market Dominance Through Reformulation: A strategic insight, provides a detailed analysis of the drug reformulation arena with emphasis on achieving and sustaining market dominance for new formulations through co-development and marketing. The report will help you develop a focused, well-planned reformulation strategy involving R&D, investment, partnering, and marketing that is crucial for long-term commercial reformulation success.
Customers who bought this item also bought
Maximizing Product Returns Through Reformulation: Old Molecules, New Opportunities
Lifecycle Management Strategies: Maximizing ROI through Indication Expansion, Reformulation and Rx-to-OTC Switching
Stakeholder Insight: Bipolar Disorders - Zyprexa Sets the Mood for Revenue Growth
The Rationale Behind Drug Reformulation: Five Case Studies and Overview of CNS Market and R&D
Pipeline Insight: Rheumatoid Arthritis and Osteoarthritis - Striving for innovation among me-toos
Market Dynamics: Antipsychotics - A Market Driven by Reformulation
Generics Defense Strategies: Effective Brand Protection through Patent, Formulation, OTC and DTC Strategies
The Top 10 Generics Companies: Strategic Insight, Growth Opportunities and Competitive Dynamics in the US and Europe
|
 |
|
|